| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |